Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


In Brief

This article was originally published in The Tan Sheet

Executive Summary

BASF casts bid for Pronova BioPharma; Bayer will not top Reckitt’s Schiff bid; FDA expands arsenal against tainted supplements; CHPA launches anti-smurfing initiative; Bovine ingredients trip Atrium; more news in brief.

You may also be interested in...

In Brief

Lawmakers push energy drink investigation; Innophos buys Triarco; BASF sweetens Pronova bid; meclizine mix-up spurs iron supplement recall; Abbott Nutrition margin growth on track; Neptune’s struggles continue; Vitamin Shoppe reaches Canada; more news In Brief.

Regulatory News In Brief

FDA warns homeopathic firm; FDA deems “no complaints” inadequate response; NAD questions urinary control claims; Refunds for Disney and Marvel vitamins; more regulatory news in brief.

DSM Makes Waves In Omega-3 Fish Oil With Ocean Nutrition Pick-Up

The Dutch ingredients company hopes to expand Ocean Nutrition Canada into a global omega-3 fish oil supplier for foods and supplements, as well as a source for pharma ingredients. With expiring IP on the Martek algal DHA process, DSM could be seeking a hedge.

Related Content


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts